[HTML][HTML] COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview …

N Luxi, A Giovanazzi, A Capuano, S Crisafulli… - Drug safety, 2021 - Springer
To date, four vaccines have been authorised for emergency use and under conditional
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …

A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease

MM Higdon, B Wahl, CB Jones… - Open Forum …, 2022 - academic.oup.com
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …

Duration of protection against mild and severe disease by Covid-19 vaccines

N Andrews, E Tessier, J Stowe, C Gower… - … England Journal of …, 2022 - Mass Medical Soc
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since …

[HTML][HTML] Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population …

C Piernas, M Patone, NM Astbury, M Gao… - The lancet Diabetes & …, 2022 - thelancet.com
Background A high BMI has been associated with a reduced immune response to
vaccination against influenza. We aimed to investigate the association between BMI and …

[HTML][HTML] Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

EPK Parker, S Desai, M Marti, H Nohynek… - The Lancet Global …, 2022 - thelancet.com
Individuals with compromised immune systems, whether because of immunodeficiency or
immuno suppressive therapy, are among those most susceptible to COVID19. In fact, people …

COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies

M Di Fusco, J Lin, S Vaghela… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Introduction From July through October of 2021, several countries issued
recommendations for increased COVID-19 vaccine protection for individuals with one or …

Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 …

J Widdifield, JC Kwong, S Chen, L Eder… - The Lancet …, 2022 - thelancet.com
Background We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease

MM Higdon, B Wahl, CB Jones, JG Rosen, SA Truelove… - MedRXiv, 2021 - medrxiv.org
Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …

Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity–the OCTAVE …

P Kearns, S Siebert, C Gaskell, A Kirkham, S Pirrie… - 2021 - papers.ssrn.com
SARS-COV-2 vaccines have been shown to be efficacious primarily in healthy volunteer
populations and population level studies. Immune responses following SARS-CoV-2 …

[HTML][HTML] Representativeness, vaccination uptake, and COVID-19 clinical outcomes 2020-2021 in the UK Oxford-Royal College of general practitioners research and …

M Leston, WH Elson, C Watson… - JMIR Public Health …, 2022 - publichealth.jmir.org
Background: The Oxford-Royal College of General Practitioners (RCGP) Research and
Surveillance Centre (RSC) is one of Europe's oldest sentinel systems, working with the UK …